1458 studies found for:    "Diabetes Mellitus, Type 1"
Show Display Options
Rank Status Study
1 Completed PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
Conditions: Type 1 Diabetes Mellitus;   Type 1 Diabetes;   Diabetes Mellitus, Insulin-Dependent;   Juvenile Diabetes
Interventions: Drug: PROCHYMAL®;   Drug: Placebo
2 Completed A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 1;   Type 1 Diabetes Mellitus
Interventions: Drug: GSK189075;   Drug: placebo
3 Active, not recruiting DIABGAD - Trial to Preserve Insulin Secretion in Type 1 Diabetes Using GAD-Alum (Diamyd) in Combination With Vitamin D and Ibuprofen
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: GAD-Alum (Diamyd) 20 µg;   Biological: GAD-Alum (Diamyd) 20 µg X 2;   Drug: Vitamin D;   Drug: Ibuprofen
4 Recruiting Accuracy of Two CGM Systems Tested Simultaneously in Ambulatory Patients With Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1;   Blood Glucose
Interventions: Device: Guardian Enlite sensor;   Device: Dexcom G4 platinum sensor
5 Completed Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes
Conditions: Type 1 Diabetes;   Preservation of Insulin Secretion;   Newly Diagnosed Type 1 Diabetes;   Canakinumab in Type 1 Diabetes
Intervention: Drug: canakinumab (anti IL-1beta)
6 Recruiting Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus
Conditions: Type 1 Diabetes;   Insulin Dependent Diabetes;   Juvenile Onset Diabetes Mellitus;   Autoimmune Diabetes
Intervention: Drug: Vildagliptin
7 Completed Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Condition: Diabetes Mellitus, Type 1
Interventions: Procedure: Mixed Meal Tolerance Test;   Procedure: Glucagon Stimulation Test
8 Recruiting Natural History Study of the Development of Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention:
9 Completed
Has Results
Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Anti-CD3 mAb;   Other: Diabetes Standard of Care Treatment;   Dietary Supplement: Iron supplementation
10 Completed Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: otelixizumab infusion plus physician determined standard of care;   Biological: placebo infusion plus physician determined standard of care
11 Recruiting Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Oral Insulin
12 Enrolling by invitation Long Term Vascular Changes in Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1;   Complications;   Coronary Heart Disease
Intervention:
13 Completed Proleukin and Rapamune in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: IL-2;   Drug: sirolimus
14 Completed Beta-Cell Transplantation in Pre-Uremic Patients With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention: Procedure: islet cell grafts
15 Completed Low Glycemic Index Diet in Patients With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention: Other: Low GI food
16 Completed Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Otelixizumab;   Biological: Placebo
17 Unknown  Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Mesenchymal Stem Cells;   Umbilical Cord
Intervention: Biological: umbilical cord mesenchymal stem cells
18 Completed
Has Results
Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Dietary Supplement: Medium chain fatty acid (Octanoic and Decanoic acid);   Other: Splenda (Placebo Control)
19 Unknown  Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Polyclonal anti-T-cell antibodies
20 Completed A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Twice Daily versus Three Times Daily Insulin Injections

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years